Image: Child undergoing scan at Dengue High Dependency Unit Negombo General Hospital 

This blog was originally published by the Dengue Vaccine Initiative.

Every three months, the Dengue Vaccine Initiative (DVI) highlights a “Dengue Champion,” calling attention to that person’s contribution to the dengue vaccine research field and their commitment to the fight against dengue fever. Dr.

by Dr. Giovanini Coelho 

Dr. Capeding led the first Phase 3 trial ever completed for a dengue vaccine candidate.

This blog was originally posed on the Dengue Vaccine Initiative website
 
This year’s Americas Dengue Prevention Board (DPB)

In a new editorial published in PLOS NTDs, “The NTDs and Vaccine Diplomacy in Latin America: Opportunities for United States Foreign Policy,” Sabin Vaccine Institute (Sabin) President Dr.

Titled, “New chapter unfolding in the fight against dengue with an unwritten ending,” the Dengue Vaccine Initiative’s (DVI) editorial just published in the October issue of Transactions

Pages